 CARMIEL, Israel, March 22, 2021 PRNewswire -- Protalix BioTherapeutics, Inc. NYSE American: PLX TASE: PLX, a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today announced that it will release its financial results for fiscal year 2020 and business update on Tuesday, March 30, 2021. The Companys management will host a conference call to discuss the financial results and provide a business update on recent corporate and clinical developments at 8:30 a.m. 